Zobrazeno 1 - 10
of 191
pro vyhledávání: '"Thierry, Conroy"'
Autor:
Leslye Rojas-Concha, Juan Ignacio Arrarrás, Thierry Conroy, Tara Chalk, Monica Guberti, Bernhard Holzner, Olga Husson, Dagmara Kuliś, Omar Shamieh, Claire Piccinin, María José Puga, Gudrun Rohde, Mogens Groenvold, on behalf the EORTC Quality of Life Group
Publikováno v:
Health and Quality of Life Outcomes, Vol 22, Iss 1, Pp 1-14 (2024)
Abstract Background The use of open-ended questions supplementing static questionnaires with closed questions may facilitate the recognition of symptoms and toxicities. The open-ended ‘Write In three Symptoms/Problems (WISP)’ instrument permits p
Externí odkaz:
https://doaj.org/article/df706ea956b9481bbc24a84f563e5c12
Did the COVID-19 pandemic delay treatment for localized breast cancer patients? A multicenter study.
Autor:
Ke Zhou, Marie Robert, Valérie Seegers, Audrey Blanc-Lapierre, Stéphane Savouroux, Frédéric Bigot, Jean-Sébastien Frenel, Mario Campone, Thierry Conroy, Frédérique Penault-Llorca, Jean-Luc Raoul, Martine M Bellanger
Publikováno v:
PLoS ONE, Vol 19, Iss 5, p e0304556 (2024)
BackgroundLonger times between diagnosis and treatments of cancer patients have been estimated as effects of the COVID-19 pandemic. However, relatively few studies attempted to estimate actual delay to treatment at the patient level.ObjectiveTo asses
Externí odkaz:
https://doaj.org/article/dc5daa6a832b496198b0d922d82d61ff
Autor:
Célia Touraine, Benjamin Cuer, Thierry Conroy, Beata Juzyna, Sophie Gourgou, Caroline Mollevi
Publikováno v:
BMC Medical Research Methodology, Vol 23, Iss 1, Pp 1-15 (2023)
Abstract Background Patient-reported outcomes such as health-related quality of life (HRQoL) are increasingly used as endpoints in randomized cancer clinical trials. However, the patients often drop out so that observation of the HRQoL longitudinal o
Externí odkaz:
https://doaj.org/article/2fb623bd4c5749f4957ebbb7bcc2f139
Publikováno v:
Annals of Surgery Open, Vol 4, Iss 2, p e288 (2023)
Externí odkaz:
https://doaj.org/article/d84712713ae64eecb196f0b2ed67d7f9
Autor:
Ke Zhou, Jean-Luc Raoul, Audrey Blanc-Lapierre, Valérie Seegers, Michèle Boisdron-Celle, Marianne Bourdon, Hakim Mahammedi, Aurélien Lambert, Camille Moreau-Bachelard, Mario Campone, Thierry Conroy, Frédérique Penault-Llorca, Martine M Bellanger, Frédéric Bigot
Publikováno v:
Clinical Medicine Insights: Oncology, Vol 16 (2022)
Background: Cancer patients (CPs) are considered more vulnerable and as a high mortality group regarding COVID-19. In this analysis, we aimed to describe asymptomatic COVID (+) CPs and associated factors. Methods: We conducted a prospective study in
Externí odkaz:
https://doaj.org/article/c904ab906e364ff9a913c197daea705d
Autor:
Caroline Bascoul-Mollevi, Sophie Gourgou, Christophe Borg, Pierre-Luc Etienne, Emmanuel Rio, Eric Rullier, Beata Juzyna, Florence Castan, Thierry Conroy
Publikováno v:
European Journal of Cancer. 186:151-165
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7ebd26f6b15585a47d2c57ea17ea720a
https://doi.org/10.1016/j.ejca.2023.03.021
https://doi.org/10.1016/j.ejca.2023.03.021
Autor:
Thierry, Conroy, Florence, Castan, Anthony, Lopez, Anthony, Turpin, Meher, Ben Abdelghani, Alice C, Wei, Emmanuel, Mitry, James J, Biagi, Ludovic, Evesque, Pascal, Artru, Thierry, Lecomte, Eric, Assenat, Lucile, Bauguion, Marc, Ychou, Olivier, Bouché, Laure, Monard, Aurélien, Lambert, Pascal, Hammel, Chris, O'Callaghan
Publikováno v:
JAMA oncology. 8(11)
ImportanceEarly results at 3 years from the PRODIGE 24/Canadian Cancer Trials Group PA6 randomized clinical trial showed survival benefits with adjuvant treatment with modified FOLFIRINOX vs gemcitabine in patients with resected pancreatic ductal ade
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d98f64a986454986ad7045715dc306c2
https://pubmed.ncbi.nlm.nih.gov/36416803
https://pubmed.ncbi.nlm.nih.gov/36416803
Publikováno v:
Bulletin du Cancer. 110:201-211
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::45d7ab72a66de9c13153974f0911aaf4
https://doi.org/10.1016/j.bulcan.2022.09.010
https://doi.org/10.1016/j.bulcan.2022.09.010
Autor:
Antoine Barbieri, Jean Peyhardi, Thierry Conroy, Sophie Gourgou, Christian Lavergne, Caroline Mollevi
Publikováno v:
BMC Medical Research Methodology, Vol 17, Iss 1, Pp 1-13 (2017)
Abstract Background The use of health-related quality of life (HRQoL) as an endpoint in cancer clinical trials is growing rapidly. Hence, research into the statistical approaches used to analyze HRQoL data is of major importance, and could lead to a
Externí odkaz:
https://doaj.org/article/9f182046cf4f4fdda214989c52bb42d8
Autor:
Christophe Borg, Olivier Bouché, Antoine Adenis, Jaafar Bennouna, Yann Touchefeu, François Ghiringhelli, Aurélie Bertaut, Julie Blanc, Thierry Conroy, Eric Francois, Jessica Gobbo, Pascal Artru
Publikováno v:
Clinical Colorectal Cancer. 21:e49-e61
Background and objectives : We have previously showed that for patients with wild-type RAS metastatic colorectal cancer (mCRC) progressing after bevacizumab plus chemotherapy, bevacizumab continuation plus a switch of chemotherapy is the most appropr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::46ed02072ac3dfb3158911b96d9dbf4d
https://doi.org/10.1016/j.clcc.2021.09.001
https://doi.org/10.1016/j.clcc.2021.09.001